An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.
Cancer Cell, 2008/1;13(1):11-22.
Hallstrom TC[1], Mori S, Nevins JR
Affiliations
PMID: 18167336DOI: 10.1016/j.ccr.2007.11.031
Impact factor: 38.585
Abstract
The Rb/E2F pathway regulates the expression of genes essential for cell proliferation but that also trigger apoptosis. During normal proliferation, PI3K/Akt signaling blocks E2F1-induced apoptosis, thus serving to balance proliferation and death. We now identify a subset of E2F1 target genes that are specifically repressed by PI3K/Akt signaling, thus distinguishing the E2F1 proliferative or apoptotic function. RNAi-mediated inhibition of several of these PI3K-repressed E2F1 target genes, including AMPK alpha 2, impairs apoptotic induction by E2F1. Activation of AMPK alpha 2 with an AMP analog further stimulates E2F1-induced apoptosis. We also show that the presence of the E2F1 apoptotic expression program in breast and ovarian tumors coincides with good prognosis, emphasizing the importance of the balance in the E2F1 proliferation/apoptotic program.
MeSH terms
AMP-Activated Protein Kinases; Aminoimidazole Carboxamide; Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; E2F1 Transcription Factor; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Models, Biological; Multienzyme Complexes; Neoplasms; Phenotype; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Rats; Repressor Proteins; Ribonucleotides; Serum; Signal Transduction
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download